Doer Biologics Announces First Patient Dosed in Phase 2 Study of DR10624 for Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

HANGZHOU, China, April 22, 2025 /PRNewswire/ — Zhejiang Doer Biologics Co., Ltd. ("Doer…

Strong Partnership for Future Momentum! Paper Chain Southeast Asia Expo + WEPACK Southeast Asia 2025 to Launch in Jakarta

SHANGHAI, April 23, 2025 /PRNewswire/ — To further strengthen the upstream and…

ChangAn Automobile Embraces Innovation with "Together for a Smarter World" Theme at Auto Shanghai 2025

SHANGHAI, April 23, 2025 /PRNewswire/ — ChangAn Automobile ("ChangAn" or "the Company"),…

Samsung Biologics reports first quarter 2025 financial results

Recorded Q1’25 consolidated revenue of KRW 1.3 trillion Recorded Q1’25 consolidated operating…

Hong Kong ICT Awards 2025 opens for enrolment

HONG KONG, April 23, 2025 /PRNewswire/ — The Hong Kong ICT Awards (HKICTA)…

YCH Group Executive Chairman Dr. Robert Yap Honoured with NTUC May Day Awards 2025 – Distinguished Service (Star) Award

SINGAPORE, April 23, 2025 /PRNewswire/ — YCH Group is proud to announce…

Sinopec Makes Overseas Debut with Global Energy Forecast: Global Energy Outlook 2060 Report Released

The Company Consolidates Common Goals and Business Cooperation in Energy Transformation with…

FUJIFILM Business Innovation Asia Pacific Honoured with Oracle Asia Pacific CHRO of the Year Award

Recognized for commitment to transformative HR practices and strategies SINGAPORE, April 23,…